Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.91 USD | +0.34% | -2.07% | -13.88% |
04-18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
04-17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
Sales 2024 * | 121M 166M | Sales 2025 * | 404M 552M | Capitalization | 4.58B 6.25B |
---|---|---|---|---|---|
Net income 2024 * | -454M -621M | Net income 2025 * | -381M -521M | EV / Sales 2024 * | 24.9 x |
Net cash position 2024 * | 1.55B 2.12B | Net cash position 2025 * | 1.39B 1.9B | EV / Sales 2025 * | 7.88 x |
P/E ratio 2024 * |
-9.82
x | P/E ratio 2025 * |
-12.7
x | Employees | 407 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on CRISPR Therapeutics AG
1 day | +0.34% | ||
1 week | -2.07% | ||
Current month | -20.91% | ||
1 month | -23.16% | ||
3 months | -11.64% | ||
6 months | +39.16% | ||
Current year | -13.88% |
Managers | Title | Age | Since |
---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 15-07-31 |
Raju Prasad
DFI | Director of Finance/CFO | 40 | 23-03-13 |
Stephen Kennedy
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
BRD | Director/Board Member | 66 | 20-06-10 |
Simeon George
BRD | Director/Board Member | 46 | 15-04-28 |
Ali Behbahani
BRD | Director/Board Member | 47 | 15-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.82% | 215 M€ | +10.68% | - | |
8.55% | 2 M€ | -25.75% | ||
4.84% | 1 M€ | 0.00% | - | |
4.53% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 53.91 | +0.34% | 1,353,533 |
24-04-25 | 53.73 | -3.45% | 1,248,652 |
24-04-24 | 55.65 | -1.35% | 920,424 |
24-04-23 | 56.41 | +1.35% | 1,190,566 |
24-04-22 | 55.66 | +1.11% | 1,044,335 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.88% | 4.58B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CRSP Stock